Patent · US Active

Pharmaceutical compositions of IL-2

US10722460B2 · kind B2 · utility

1Cited by

2References

17Claims

0Family size

Assignee

ILTOO PHARMA · FR

Inventors

Jérémie Mariau · Fontenay-sous-Bois, FR
Michel Thiry · Trooz, BE

Key dates

Filing date	Oct 20, 2016
Grant date	Jul 28, 2020
Priority date	—
Expiry date	Nov 14, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61J1/05
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a liquid pharmaceutical composition of Il-2 and its use in the treatment of auto-immune and inflammatory disorders. Methods for preparing said composition and delivery devices filled with said composition are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.